Women's Cardiovascular Risk Starts Earlier and Differs More Than Medicine Recognizes
Cardiovascular disease quietly claims more women's lives than breast cancer, lung cancer, and chronic obstructive pulmonary disease combined — yet a…
Found 2067 results for "cancer"
Cardiovascular disease quietly claims more women's lives than breast cancer, lung cancer, and chronic obstructive pulmonary disease combined — yet a…
For the roughly one million people globally living with both HIV and hepatitis C, clearing the hepatitis C virus has long been understood as a liver-saving…
For colorectal cancer patients, the intensity of the body's post-surgical inflammatory surge may be as consequential as the operation itself — influencing…
For patients who have already been treated for high-grade precancerous lesions, the window for HPV vaccination may have permanently closed. This finding…
The immune system's ability to generate diverse, high-affinity antibodies depends on a precise and potentially dangerous process of controlled DNA mutation…
The promise of training the immune system to selectively destroy tumor cells — while sparing healthy tissue — has long been oncology's most elegant…
The relationship between the gut microbiome and cancer risk has moved well beyond correlation — emerging evidence now suggests that specific patterns of…
Treatment-resistant cancer stem cells are a primary reason why head and neck squamous cell carcinoma (HNSCC) remains lethal even after aggressive therapy. A…
Glioblastoma remains one of oncology's most formidable challenges — median survival after recurrence is measured in months, and the blood-brain barrier has…
Colorectal cancer rates climb steeply after age 60, yet the biological explanation has remained frustratingly incomplete. A comprehensive review published in…
For anyone tracking the frontiers of cancer biology or RASopathy research, understanding precisely how Ras proteins are controlled at the molecular level has…
Lung metastasis is the dominant killer in triple-negative breast cancer, the subtype with the fewest targeted treatment options and the worst prognosis. A…
Pancreatic cancer kills with grim efficiency partly because the molecular machinery driving it has resisted every attempt at targeted therapy. A new compound…
For families carrying a germline TP53 mutation, childhood is not a reprieve from cancer risk — it is the period when surveillance arguably matters most…
Brain cancer research has long been constrained by the poor predictive accuracy of traditional cell lines and animal models — a gap that may explain why…
Most immunology textbooks treat cytotoxic killing as the exclusive province of blood-derived cells — T cells, natural killer cells, neutrophils. A discovery…
Understanding how cancers accumulate genetic errors is foundational to improving early detection and therapeutic targeting. A significant piece of that puzzle…
For decades, vitamin D's immune benefits have been described in broad strokes — anti-inflammatory, gut-protective — without a clear molecular blueprint…
As gonorrhea quietly becomes untreatable with conventional antibiotics, a fundamentally different weapons platform is entering the conversation — one borrowed…
Metabolic reprogramming is now recognized as a hallmark of aggressive cancers, but pinpointing the molecular switches that redirect cellular metabolism toward…